1.42

2.90% 0.04

After Hours: 1.44 0.02 +1.41%

Co Diagnostics Inc (CODX)

Overview News Price History Option Chain Financials Discussions Forecast

Co Diagnostics Inc stock is traded at $1.42, with a volume of 78,050. It is up +2.90% in the last 24 hours and down -49.29% over the past month. Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Previous Close:

$1.38

Open:

$1.41

24h Volume:

78,050

Relative Volume:

0.07

Market Cap:

$5.12M

Revenue:

$418.20K

Net Income/Loss:

$-46.90M

P/E Ratio:

-0.0587

EPS:

-24.1892

Net Cash Flow:

$-29.84M

1W Performance:

+2.16%

1M Performance:

-49.29%

6M Performance:

-64.22%

1Y Performance:

-87.42%

1-Day Range:

$1.38

$1.45

1-Week Range:

$1.35

$1.50

52-Week Range:

$1.35

$3.95

Co Diagnostics Inc Stock (CODX) Company Profile

Name

Co Diagnostics Inc

Sector

Healthcare (1112)

Industry

Medical Devices (143)

Phone

(801) 438-1036

Address

2401 S FOOTHILL DRIVE, SALT LAKE CITY

Employee

115

Twitter

Next Earnings Date

2026-03-31

Latest SEC Filings

CODX's Discussions on Twitter

Compare CODX vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CODX Co Diagnostics Inc	1.42	4.97M	418.20K	-46.90M	-29.84M	-24.19
ABT Abbott Laboratories	101.56	175.59B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	341.24	132.47B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	87.10	113.14B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	64.61	94.85B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	78.20	45.09B	6.07B	1.06B	1.34B	1.8063

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-12-22	Downgrade	Sidoti	Buy → Neutral
Dec-29-21	Initiated	Sidoti	Buy
Mar-29-21	Downgrade	Maxim Group	Buy → Hold
May-20-20	Upgrade	Maxim Group	Hold → Buy
May-18-20	Reiterated	H.C. Wainwright	Buy
Mar-09-20	Reiterated	H.C. Wainwright	Buy
Mar-03-20	Downgrade	Maxim Group	Buy → Hold

View All

Co Diagnostics Inc Stock (CODX) Latest News

Apr 14, 2026

Co-Diagnostics (CODX) price target decreased by 20.00% to 30.60 - MSN

Apr 14, 2026

Co-Diagnostics to show new PCR platform at Munich infection meeting - Stock Titan

Apr 14, 2026

Co-Diagnostics (CODX) price target decreased by 37.50% to 1.28 - MSN

Apr 14, 2026

Apr 13, 2026

symbol__ Stock Quote Price and Forecast - CNN

Apr 13, 2026

Apr 10, 2026

Investment Review: What analysts say about Co Diagnostics Inc stockProfit Target & Daily Volume Surge Trade Alerts - baoquankhu1.vn

Apr 10, 2026

CODX Technical Analysis | Trend, Signals & Chart Patterns | CO-DIAGNOSTICS INC (NASDAQ:CODX) - ChartMill

Apr 10, 2026

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah - BioSpace

Apr 10, 2026

Apr 09, 2026

Co-Diagnostics Executives to Participate in European Trade Missi - GuruFocus

Apr 09, 2026

Portfolio Update: Is Co Diagnostics Inc benefiting from interest rate changesMarket Movement Recap & Low Risk High Reward Ideas - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Aug Drivers: Can Co Diagnostics Inc scale operations efficientlyWatch List & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Apr 08, 2026

Bull Bear: What analysts say about Co Diagnostics Inc stockTrade Risk Assessment & Real-Time Stock Entry Alerts - baoquankhu1.vn

Apr 08, 2026

Apr 06, 2026

COVID-19 Detection Kits Market Set to Boom Rapidly by 2033 | - openPR.com

Apr 06, 2026

Apr 05, 2026

Co-Diagnostics Q4 2025 earnings preview - MSN

Apr 05, 2026

Apr 03, 2026